SCHEMBL5601022

SCHEMBL5601022

CN(C)C(Cl)COc1ccc(Cc2nccn2C)cc1OCC(Cl)N(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
POLB P06746 2/20 0.34
MAPK1 P28482 4/20 0.33
TRPM5 Q9NZQ8 1/20 0.33
TSHR P16473 2/20 0.33
CYP3A4 P08684 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CHRM1 P11229 1/20 0.33
CYP2C9 P11712 1/20 0.33
DRD1 P21728 1/20 0.33
TBXA2R P21731 1/20 0.33
PDE4A P27815 1/20 0.33
ADRA1A P35348 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5601356 0.88 CHRNB2 (0.39) LMNAALDH1A1KMT2AMEN1POLB
SCHEMBL5601407 0.84 MEN1 (0.44) LMNAKMT2AMEN1MAPK1TSHR
SCHEMBL5600396 0.82 POLB (0.40) LMNAALDH1A1KMT2AMEN1POLB
SCHEMBL1008065 0.75 CA2 (0.56) LMNAALDH1A1KMT2AMEN1POLB
SCHEMBL5599079 0.75 KMT2A (0.42) LMNAKMT2AMEN1MAPK1SMN1; SMN2
Bromide SCHEMBL2192386 0.74 CA2 (0.54) LMNAALDH1A1KMT2AMEN1POLB
SCHEMBL5601238 0.74 POLB (0.39) ALDH1A1KMT2AMEN1POLBMAPK1
SCHEMBL16879029 0.72 MAPK1 (0.47) LMNAALDH1A1MAPK1SMN1; SMN2PDE3A
SCHEMBL6650490 0.69 MEN1 (0.37) KMT2AMEN1TSHRMAPTOPRK1
SCHEMBL5599192 0.69 LMNA (0.36) LMNAKMT2ASMN1; SMN2CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed
EP-1746986-A1 ACTIVE SUBSTANCE COMBINATION COMPRISING A CARBINOL COMBINED TO AT LEAST AN NSAID LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-31 EP disclosed
WO-2005097099-A1 ACTIVE SUBSTANCE COMBINATION COMPRISING A CARBINOL COMBINED TO AT LEAST AN NSAID LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2005-10-20 WO disclosed